联邦 发表于 2025-3-25 03:40:03

Submitted on: 26 August 2007.
Revised on: 02 November 2007.
Accepted on: 10 December 2007.

___________________Journal of Pharmaceutical Investigation

Exhilarate 发表于 2025-3-25 09:31:10

Submitted on: 10 March 2006.
Revised on: 11 April 2006.
Accepted on: 29 May 2006.

___________________Journal of Pharmaceutical Investigation

dermatomyositis 发表于 2025-3-25 12:27:25

Submitted on: 29 November 2002.
Revised on: 12 February 2003.
Accepted on: 29 March 2003.

___________________Journal of Pharmaceutical Investigation

mosque 发表于 2025-3-25 17:32:56

http://reply.papertrans.cn/2/187/18691/18691-24.png

关心 发表于 2025-3-25 20:43:39

http://reply.papertrans.cn/2/187/18691/18691-25.png

nugatory 发表于 2025-3-26 02:39:07

http://reply.papertrans.cn/2/187/18691/18691-26.png

defibrillator 发表于 2025-3-26 07:53:29

Submitted on: 01 December 2010.
Revised on: 24 December 2010.
Accepted on: 19 January 2011.

___________________Journal of Pharmaceutical Investigation

结合 发表于 2025-3-26 11:29:06

http://reply.papertrans.cn/2/187/18691/18691-28.png

CRAFT 发表于 2025-3-26 14:08:41

http://reply.papertrans.cn/2/187/18691/18691-29.png

Oligarchy 发表于 2025-3-26 17:05:33

http://reply.papertrans.cn/2/187/18691/18691-30.png
页: 1 2 [3] 4
查看完整版本: SCIE期刊Journal of Pharmaceutical Investigation 2024/2025影响因子:5.377 (J PHARM INVEST) (2093-5552). (PHARMACOLOGY & PHARMAC